Gottlieb at BIO: FDA developing processes around right-to-try law
FDA commissioner gives clues of agency's right-to-try strategy in Q&A session during chat with BIO President Jim Greenwood.
P4HD Partners respond to USA Today letter written by John J. Castellani & Jim Greenwood
On February 24, USA Today ran a letter to the editor written by PhRMA President John J. Castellani and Biotechnology Industry Organization President Jim Greenwood responding to an editorial that not only mischaracterized the relationships between physicians and biopharmaceutical and medical technology professionals, but also admonished them. An additional rebuttal by Dr. Thomas Stossel, Professor […]
presented by
How to Optimize Your Phlebotomy Setup for Efficient Patient Care
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Senate passes JOBS bill, but will early stage biotech companies benefit?
The U.S. Senate has approved a bill that will make it easier for early stage companies to raise money by broadening the number of people that can invest in them and help companies file for initial public offerings. But will it mean more biotechnology startups will have the money to survive the multiyear journey to […]